Patrick, MelpoSophisticated scientific testing methods supported new biomolecular archaeological evidence to uncloak medicinal remedies that were previously identified, tested and generally lost throughout millennia of human history. This included herbs, tree resins and other organic materials provided through ancient fermented beverages like wine and beer.

Now the question arises if we could employ these remedies to help sick people today. Experts from the University of Pennsylvania Museum’s Biomolecular Archaeology Laboratory and Penn Medicine’s Abramson Cancer Center appear to have identified a positive response of these herbal additives through laboratory testing.

For the past two years experts have been analyzing a project known as Archaeological Oncology: Digging for Drug Discovery. They have been testing compounds available among various ancient fermented beverages from China and Egypt in order to reveal their anti-cancer functions.

“Artesunate is an old drug that has been used in humans for malaria, but now it is being rediscovered for use against lung cancer. Analysis of artesunate showed potent anticarcinogenic properties in lung cancer cells—a very encouraging sign. We are ready to take these findings, and this ancient/modern compound, to the next stage in testing,” elucidates
Co-author Melpo Christofidou-Solomidou, PhD, research associate professor in the Division of Pulmonary, Allergy and Critical Care and an Abramson Cancer Center Investigator.

Many compounds displayed significant and positive test activity against lung and colon cancer. These compounds included luteolin from sage and ursolic acid collected from thyme and other herbs sustained in ancient Egyptian wine jars, ca 3150 BCE, and artemisinin and its synthetic derivative, artesunate, and isoscopolein gained from wormwood species Artemisia, which laced an ancient Chinese rice wine, ca 1050 BCE. Additionally experts anticipate testing these compounds against lung cancer among animal models.

A review of the study and findings are available in the July 2010 issue of International Journal of Oncology.